News
Why Shares of CTI BioPharma Are Soaring Wednesday
Shares of CTI BioPharma (NASDAQ: CTIC) were up more than 80% early Wednesday after the company announced it was getting bought out for $1.7 billion by Swedish Orphan Biovitrum AB (OTC: BIOVF), also
Why Shares of Grifols Were Up Tuesday
Shares of Grifols (NASDAQ: GRFS) were up 11.1% on Tuesday afternoon, after being up as much as 13.1% earlier in the day. The pharmaceutical company, which makes plasma-derived medicines, released
3 Best Marijuana Stocks to Buy in May
Sometimes, you have to turn over a new leaf when you're looking for marijuana stocks to invest in. There's plenty of long-term growth anticipated for the industry, but short-term headwinds have sent
Is Curaleaf Stock a Buy Now?
Curaleaf (OTC: CURLF) is one of the leaders in the American cannabis industry, serving as a leading medical and recreational marijuana dispensary in 19 states. But in the last six months alone its
This Beaten-Down Stock Could Be a Great Contrarian Opportunity
Many experts are predicting the death of office real estate. While it's true that the remote work trend and rising rate economy are creating a difficult environment, Empire State Realty Trust (NYSE:
Shofu Dental Brasil, Super-Bond™ Dental Adhesive to Launch in Brazil
SHOFU INC. (Tokyo: 7979; President & COO: TAKAMI Tetsuo), SUN MEDICAL CO., LTD. (Head Office: Moriyama, Shiga; President & CEO: NAKAJIMA Yoshiyuki) and Mitsui Chemicals, Inc. (Tokyo: 4183
Shofu Dental Brasil, Super-Bond™ Dental Adhesive to Launch in Brazil
SHOFU INC. (Tokyo: 7979; President & COO: TAKAMI Tetsuo), SUN MEDICAL CO., LTD. (Head Office: Moriyama, Shiga; President & CEO: NAKAJIMA Yoshiyuki) and Mitsui Chemicals, Inc. (Tokyo: 4183
Shofu Dental Brasil, Super-Bond™ Dental Adhesive to Launch in Brazil
SHOFU INC. (Tokyo: 7979; President & COO: TAKAMI Tetsuo), SUN MEDICAL CO., LTD. (Head Office: Moriyama, Shiga; President & CEO: NAKAJIMA Yoshiyuki) and Mitsui Chemicals, Inc. (Tokyo: 4183
Shofu Dental Brasil, Super-Bond™ Dental Adhesive to Launch in Brazil
SHOFU INC. (Tokyo: 7979; President & COO: TAKAMI Tetsuo), SUN MEDICAL CO., LTD. (Head Office: Moriyama, Shiga; President & CEO: NAKAJIMA Yoshiyuki) and Mitsui Chemicals, Inc. (Tokyo: 4183
Shofu Dental Brasil, Super-Bond™ Dental Adhesive to Launch in Brazil
SHOFU INC. (Tokyo: 7979; President & COO: TAKAMI Tetsuo), SUN MEDICAL CO., LTD. (Head Office: Moriyama, Shiga; President & CEO: NAKAJIMA Yoshiyuki) and Mitsui Chemicals, Inc. (Tokyo: 4183
Got $10,000? 2 Magnificent Growth Stocks to Buy Before They Skyrocket
The more money you put into the stock market, the greater your gains will be -- that is, if you're patient and choose wisely. An investment of $10,000 could help set the foundation for life-changing
GenSight Biologics Announces Presentation of LUMEVOQ® Efficacy and Safety Data from Early Access Programs for ND4-LHON Patients at NANOS 2023
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230314006021/en/
Figure 1: Global evolution of mean BCVA over two
Innovation zur Resistenzbekämpfung: VECTRONTM T500, ein neues Produkt zur Vektorkontrolle, wurde von der Weltgesundheitsorganisation (WHO) präqualifiziert
VECTRONTM T500 ist ein neues IRS-Produkt, das TENEBENALTM enthält, den weltweit ersten Meta-Diamid-Wirkstoff (IRAC-Gruppe 30), der von Mitsui Chemicals Agro entwickelt wurde und sich in seiner
Innovation zur Resistenzbekämpfung: VECTRONTM T500, ein neues Produkt zur Vektorkontrolle, wurde von der Weltgesundheitsorganisation (WHO) präqualifiziert
VECTRONTM T500 ist ein neues IRS-Produkt, das TENEBENALTM enthält, den weltweit ersten Meta-Diamid-Wirkstoff (IRAC-Gruppe 30), der von Mitsui Chemicals Agro entwickelt wurde und sich in seiner
Innovation zur Resistenzbekämpfung: VECTRONTM T500, ein neues Produkt zur Vektorkontrolle, wurde von der Weltgesundheitsorganisation (WHO) präqualifiziert
VECTRONTM T500 ist ein neues IRS-Produkt, das TENEBENALTM enthält, den weltweit ersten Meta-Diamid-Wirkstoff (IRAC-Gruppe 30), der von Mitsui Chemicals Agro entwickelt wurde und sich in seiner
Innovation zur Resistenzbekämpfung: VECTRONTM T500, ein neues Produkt zur Vektorkontrolle, wurde von der Weltgesundheitsorganisation (WHO) präqualifiziert
VECTRONTM T500 ist ein neues IRS-Produkt, das TENEBENALTM enthält, den weltweit ersten Meta-Diamid-Wirkstoff (IRAC-Gruppe 30), der von Mitsui Chemicals Agro entwickelt wurde und sich in seiner
Innovation zur Resistenzbekämpfung: VECTRONTM T500, ein neues Produkt zur Vektorkontrolle, wurde von der Weltgesundheitsorganisation (WHO) präqualifiziert
VECTRONTM T500 ist ein neues IRS-Produkt, das TENEBENALTM enthält, den weltweit ersten Meta-Diamid-Wirkstoff (IRAC-Gruppe 30), der von Mitsui Chemicals Agro entwickelt wurde und sich in seiner
Innovation in Resistance Management: VECTRONTM T500, a New Vector Control Product, is Prequalified by the World Health Organization (WHO)
VECTRONTM T500 is a new IRS product containing TENEBENALTM, the world’s first meta-diamide active ingredient (IRAC Group 30) developed by Mitsui Chemicals Agro which has a different mode of action
Innovation in Resistance Management: VECTRONTM T500, a New Vector Control Product, is Prequalified by the World Health Organization (WHO)
VECTRONTM T500 is a new IRS product containing TENEBENALTM, the world’s first meta-diamide active ingredient (IRAC Group 30) developed by Mitsui Chemicals Agro which has a different mode of action
Innovation in Resistance Management: VECTRONTM T500, a New Vector Control Product, is Prequalified by the World Health Organization (WHO)
VECTRONTM T500 is a new IRS product containing TENEBENALTM, the world’s first meta-diamide active ingredient (IRAC Group 30) developed by Mitsui Chemicals Agro which has a different mode of action
Innovation in Resistance Management: VECTRONTM T500, a New Vector Control Product, is Prequalified by the World Health Organization (WHO)
VECTRONTM T500 is a new IRS product containing TENEBENALTM, the world’s first meta-diamide active ingredient (IRAC Group 30) developed by Mitsui Chemicals Agro which has a different mode of action
Innovation in Resistance Management: VECTRONTM T500, a New Vector Control Product, is Prequalified by the World Health Organization (WHO)
VECTRONTM T500 is a new IRS product containing TENEBENALTM, the world’s first meta-diamide active ingredient (IRAC Group 30) developed by Mitsui Chemicals Agro which has a different mode of action
GenSight Biologics Confirms Sustained Efficacy and Safety of Bilateral LUMEVOQ® Injections at 3-Year Follow-Up of REFLECT Phase III Trial
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230312005028/en/
Graph 1: Evolution of Best-Corrected Visual Acuity